Treatment modalities in endometrial cancer

Current Opinion in Oncology

Volumn 19, Issue 5, 2007, Pages 479-485

  Amant, Frederic ^a   Moerman, Philippe ^a   Neven, Patrick ^a   Timmerman, Dirk ^a   Van Limbergen, Erik ^a   Vergote, Ignace ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chemotherapy; Endometrial cancer; Radiotherapy; Surgery; Therapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; MEDROXYPROGESTERONE ACETATE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; ASCITES FLUID CYTOLOGY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LYMPH NODE; LYMPH NODE DISSECTION; NAUSEA AND VOMITING; OVERALL SURVIVAL; PERITONEAL CAVITY; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SALPINGOOOPHORECTOMY; SURVIVAL RATE; SURVIVAL TIME; TRANSVAGINAL ECHOGRAPHY;

COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS;

EID: 34548389329     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32827853c0     Document Type: Review

References (60)

1. Gatta G, Lasota M, Verfecchia A, The EUROCARE Working Group. Survival of European women with gynaecological tumours during the period 1978-89. Eur J Cancer 1998; 34:2218-2225.
2. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003; 53:27-43.
3. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005; 366:591-605.
4. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002; 9:145-184.
5. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983; 15:10-17.
6. Hendrickson MR, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982; 6:93-108.
7. Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol 2003; 91:463-469.
8. Abeler VM, Kjorstad KE. Clear cell carcinoma of the endometrium: a histopathological and clinical study of 31 cases. Cancer 1991; 68:98-105.
9. Darvishian F, Hummer AJ, Thaler HT, et al. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol 2004; 28:1568-1578.
10. Sherman M, Sturgeon S, Brinton L, et al. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol 1997; 10:963-968.
11. Goff B, Kato D, Schmidt R, et al. Uterine papillary serous carcinoma: patterns of spread. Gynecol Oncol 1994; 54:264-268.
12. Ronnett B, Zaino R, Ellenson L, et al. Endometrial carcinoma. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract, 5th ed. New York: Springer; 2002. pp. 501-560.
13. Amant F, Cadron I, Fuso L, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high risk epithelial endometrial cancer. Gynecol Oncol 2005; 98:274-280.
14. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999; 212:711-718.
15. Franchi M, Ghezzi F, Melpignano M, et al. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol Oncol 2000; 76:357-361.
16. Kucera E, Kainz C, Reinthaller A, et al. Accuracy of intraoperative frozen-section diagnosis in stage I endometrial adenocarcinoma. Gynecol Obstet Invest 2000; 49:62-66.
17. Yu CK, Cutner A, Mould T, et al. Total laparoscopic hysterectomy as a primary surgical treatment for endometrial cancer in morbidly obese women. BJOG 2005; 112:115-117.
18. Walker J, Mannel R, Piedmonte M, et al. Phase III trial of laparoscopy versus laparotomy for surgical resection and comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group study funded by the National Cancer Institute [abstract]. Gynecol Oncol 2006; 101:S11.
19. Sonoda Y, Zerbe M, Smith A, et al. High incidence of positive peritoneal cytology in low risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol 2001; 80:378-382.
20. Vergote I, De Smet I, Amant F. High incidence of positive peritoneal cytology in low risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy [letter]. Gynecol Oncol 2002; 84:537-539.
21. Schneider A. Vaginal cuff recurrence of endometrial cancer treated by laparoscopic assisted vaginal hysterectomy. Gynecol Oncol 2004; 94: 861-863.
22. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. Cancer 1987; 60:2035-2041.
23. Boronow R, Morrow C, Creasman W, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984; 63:825-832.
24. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56:29-33.
25. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005; 23:3668-3675.
26. Kitchener H, Redman C, Swart A, et al. ASTEC (surgery component): a study in the treatment of endometrial cancer: a randomized trial of lymphadenectomy in the treatment of endometrial cancer [abstract]. Int J Gynecol Cancer 2005; 15:77.
27. Mariani A, Dowdy SC, Keeney GL, et al. High-risk endometrial cancer subgroups: candidates for target-based adjuvant therapy. Gynecol Oncol 2004; 95:120-126.
28. Kalogiannidis I, Lambrechts S, Amant F, et al. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. Am J Obstet Gynecol 2007; 196:248.e1-248.e8. A single centre report emphasizing the safety and feasibility of a laparoscopic staging procedure in endometrial cancer.
29. Kalogiannidis I, Lambrechts S, Amant F, et al. Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: an analysis of 208 patients. Int J Gynecol Cancer 2006; 16: 1885-1893.
30. Mariani A, Webb M, Keeney G, et al. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000; 182:1506-1519.
31. Creasman WT, Kohler MF, Odicino F, et al. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol 2004; 95:593-596.
32. Bristow R, Zerbe M, Rosensheim N, et al. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 2000; 78:85-91.
33. Podratz K, Mariani A. Uterine papillary serous carcinomas: the exigency for clinical trials. Gynecol Oncol 2003; 91:461-462.
34. Huh W, Powell M, Leath C, et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol 2003; 91:470-475.
35. Abeler V, Vergote I, Kjorstad K, et al. Clear carcinoma of the endometrium: prognosis and metastatic spread pattern. Cancer 1996; 78:1740-1747.
36. Trimbos B, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant Chemo Therapy in Ovarian Neoplasm Trial. J Natl Ca Instit 2003; 95:113-125.
37. Geisler JP, Geisler HE, Melton ME, et al. What staging surgery should be performed on patients with uterine papillary serous carcinoma? Gynecol Oncol 1999; 74:465-467.
38. Memarzadeh S, Holschneider CH, Bristow RE, et al. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival. Int J Gynecol Cancer 2002; 12:454-458.
39. Despierre E, Moerman P, Vergote I, et al. Is there a role for neoadjuvant chemotherapy in the treatment of stage IV uterine papillary serous carcinoma? Int J Gynecol Cancer 2006; 16:273-277.
40. Aalders J, Abeler V, Kolstad P, et al. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol Oncol 2004; 94:861-863.
41. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004; 22:1234-1241.
42. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004; 92:744-751.
43. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000; 355:1404-1411.
44. Einhorn N, Trope C, Ridderheim M, et al. A systematic overview of radiation therapy effects in uterine cancer (corpus uteri) [review]. Acta Oncol 2003; 42:557-561.
45. Morrow CP, Bundy BN, Homesley HD, et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. Gynecol Oncol 1990; 36:166-171.
46. Vergote I, Kjorstad K, Abeler V, et al. A randomized trial of adjuvant progestagen in early endometrial cancer. Cancer 1989; 64:1011-1016.
47. Rosenberg P, Boeryd B, Simonsen E. A new aggressive approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol 1993; 48:32-37.
48. Elit L, Kwon J, Bentley J, et al. Optimal management for surgical stage I serous cancer of the uterus. Gynecol Oncol 2004; 92:240-246.
49. Dietrich C, Modesitt S, DePriest P, et al. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol 2005; 99:557-563.
50. Kelly M, O'Malley D, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 2005; 98:353-359.
51. Lentz SS, Brady MF, Major FJ, et al. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 1996; 14:357-361.
52. Ferrandina G, Zannoni G, Gallotta V, et al. Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol 2005; 99:215-217.
53. Barrett R, Blessing J, Homesley H, et al. Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma: a phase II study of the Gynecologic Oncology Group. Am J Clin Oncol 1993; 16:494-496.
54. Tropé C, Johnsson J, Simonsen E, et al. Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin. Am J Obstet Gynecol 1984; 149:379-381.
55. Long H, Pfeifle D, Wiand H, et al. Phase II evaluation of carboplatin in advanced endometrial carcinoma. J Natl Cancer Inst 1988; 80:276-278.
56. Burke T, Munkarah A, Kavanagh J, et al. Treatment of advanced or recurrent endometrial carcinoma with single-agent carboplatin. Gynecol Oncol 1993; 51:397-400.
57. Aapro M, van Wijk F, Bolis G, et al. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definite results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 2003; 14:441-448.
58. Thigpen JT, Brady MF, Homesley HD, et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 2004; 22:3902-3908.
59. Randall ME, Brunetto G, Muss HB, et al. Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. J Clin Oncol 2006; 24:36-44. One of the most important recent studies that suggests chemotherapy is better than whole abdominal radiotherapy after surgery for stage III and IV endometrial cancer.
60. Hoskins P, Swenerton K, Pike J, et al. Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol 2001; 19:4048-4053.